Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature

L Budäus, M Bolla, A Bossi, C Cozzarini, J Crook… - European urology, 2012 - Elsevier
CONTEXT: Prostate cancer (PCa) patients have many options within the realms of surgery
or radiation therapy (RT). Technical advancements in RT planning and delivery have …

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study

M Bolla, G Van Tienhoven, P Warde, JB Dubois… - The lancet …, 2010 - thelancet.com
Background We did a randomised phase 3 trial assessing the benefit of addition of long-
term androgen suppression with a luteinising-hormone-releasing hormone (LHRH) agonist …

Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy

STH Peeters, WD Heemsbergen… - Journal of Clinical …, 2006 - ascopubs.org
Purpose To determine whether a dose of 78 Gy improves outcome compared with a
conventional dose of 68 Gy for prostate cancer patients treated with three-dimensional …

Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer

BA Jereczek-Fossa, R Orecchia - Radiotherapy and Oncology, 2007 - Elsevier
The standard treatment options based on the risk category (stage, Gleason score, PSA) for
localized prostate cancer include surgery, radiotherapy and watchful waiting. The literature …

Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer

S Arcangeli, L Strigari, S Gomellini, B Saracino… - International Journal of …, 2012 - Elsevier
PURPOSE: To report long-term results and patterns of failure after conventional and
hypofractionated radiation therapy in high-risk prostate cancer. METHODS AND …

High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial

A Zapatero, A Guerrero, X Maldonado… - The Lancet …, 2022 - thelancet.com
Background The optimal duration of androgen deprivation combined with high-dose
radiotherapy in prostate cancer remains controversial. The DART 01/05 trial was designed …

High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer

DR Zwahlen, N Andrianopoulos, B Matheson… - Brachytherapy, 2010 - Elsevier
PURPOSE: To report long-term outcomes for treatment of prostate cancer using dose
escalation with high-dose-rate (HDR) brachytherapy and 3-dimensional conformal external …

Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer

G Arcangeli, L Strigari, S Arcangeli… - International Journal of …, 2009 - Elsevier
PURPOSE: Because of the lack of conclusive and well-conducted randomized studies, the
optimal therapy for prostate tumors remains controversial. The aim of this study was to …

Long‐term outcomes for men with high‐risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation

QN Nguyen, LB Levy, AK Lee, SS Choi, SJ Frank… - Cancer, 2013 - Wiley Online Library
BACKGROUND Men with high‐risk prostate cancer are often thought to have very poor
outcomes in terms of disease control and survival even after definitive treatment. However …

External-Beam Radiation Therapy and High–Dose Rate Brachytherapy Combined With Long-Term Androgen Deprivation Therapy in High and Very High Prostate …

R Martínez-Monge, M Moreno, R Ciérvide… - International Journal of …, 2012 - Elsevier
PURPOSE: To determine the feasibility of combined long-term androgen deprivation therapy
(ADT) and dose escalation with high-dose-rate (HDR) brachytherapy. METHODS AND …